Identity
- Trade Name
- DILUENT FDA UDI
- Generic Name
- Immunohistochemistry antibody diluent IVD FDA UDI
- Model / Reference
- HK165-5K FDA UDI
Identifiers
- Catalog Number
- HK165-5K FDA UDI
- Primary DI / UDI-DI
- 00810119678508 FDA UDI
- FDA Product Code
- NJT FDA UDI
- GMDN Term
- Immunohistochemistry antibody diluent IVD FDA UDI
Classification
- Device Class
- Class I FDA UDI
- Regulation Number
- 864.1860 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Immunohistochemistry antibody diluent IVD
Diluent by Biogenex Laboratories, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Immunohistochemistry antibody diluent IVD.
- Da Vinci Green Diluent — BIOCARE MEDICAL, LLC · Class I
- Immunalysis — Immunalysis Corporation · Class I
- ImmunoDNA Background Blocker — BIO SB, INC. · Class I
- Immunalysis — Immunalysis Corporation · Class I
- ImmunoDNA Background Blocker — BIO SB, INC. · Class I
- Van Gogh Yellow Diluent — BIOCARE MEDICAL, LLC · Class I
- ImmunoDetector Protein Blocker / Antibody Diluent — BIO SB, INC. · Class I
- Immunalysis — Immunalysis Corporation · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class I | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Biogenex Laboratories, Inc.
Sources (1)
- FDA UDI a55ec2c0-66bd-4d20-9460-8723e553a561 35 fields · synced May 30, 2026